Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Are guidelines on use of colony-stimulating factors in solid cancers flawed?

Haines IE, Olver I

(2009), Intern Med J, 39(4), 259-62

A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia

Haines I, Elliott P, Stanley R

(2009), Intern Med J, 39(4), 269-71

Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Giobbie-Hurder A, Price KN, Gelber RD; International Breast Cancer Study Group; BIG 1-98 Collaborative Group

(2009), Clin Trials, 6(3), 272-87

Lack of knowledge of hormone receptor status and use of endocrine therapy in invasive breast cancer

Bell RJ, Lijovic M, Fradkin P, Bradbury J, La China M, Schwarz M, Wolfe R, Farrugia H, Davis SR

(2009), J Womens Health, 18(12), 1975-80

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer

Viale G, Regan MM, Mastropasqua MG, Maffini F, Maiorano E, et al; International Breast Cancer Study Group

(2008), J Natl Cancer Inst, 100(3), 207-12

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study G

Viale G, Regan MM, Maiorano E, Mastropasqua MG, Golouh R, Perin T, Brown RW, Kovacs A, Pillay K, Ohlschlegel C, Braye S, Grigolato P, Rusca T, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS

(2008), J Clin Oncol, 26(9), 1404-10

Re: Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial

Sari E, Bulut N, Altundag K

(2008), J Natl Cancer Inst, 100(9), 683

p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer

Ravaioli A, Monti F, Regan MM, Maffini F, Mastropasqua MG, Spataro V, Castiglione-Gertsch M, Panzini I, Gianni L, Goldhirsch A, Coates A, Price KN, Gusterson BA, Viale G; International Breast Cancer Study Group

(2008), Ann Oncol, 19(4), 660-8

K-ras mutations and benefit from cetuximab in advanced colorectal cancer

Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR

(2008), N Engl J Med, 359(17), 1757-65

Inferior vena caval leiomyosarcoma in a patient with past bilateral retinoblastoma.

Hawkes E, Haydon A, Murugasu A, Schwarz MA

(2008), Asia Pacific J Clin Oncol, 4(3), 181–3

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.

Gruber G, Cole BF, Castiglione-Gertsch M, Holmberg SB, Lindtner J, Golouh R, Collins J, Crivellari D, Thurlimann B, Simoncini E, Fey MF, Gelber RD, Coates AS, Price KN, Goldhirsch A, Viale G, Gusterson BA; International Breast Cancer Study Group

(2008), Ann Oncol, 19(8), 1393-401

Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.

Gianni L, Cole BF, Panzini I, Snyder R, Holmberg SB, Byrne M, Crivellari D, Colleoni M, Aebi S, Simoncini E, Pagani O, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS, Ravaioli A

(2008), Support Care Cancer, 16(1), 67-74

Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype

English DR, Young JP, Simpson JA, Jenkins MA, Southey MC, Walsh MD, Buchanan DD, Barker MA, Haydon AM, Royce SG, Roberts A, Parry S, Hopper JL, Jass JJ, Giles GG

(2008), Cancer Epidemiol Biomarkers Prev, 17(7), 1774-80

Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma

Ranson M, Hersey P, Thompson D, Beith J, McArthur GA, Haydon A, Davis ID, Kefford RF, Mortimer P, Harris PA, Baka S, Seebaran A, Sabharwal A, Watson AJ, Margison GP, Middleton MR

(2007), J Clin Oncol, 25(18), 2540-5

Anger in palliative care: a clinical approach

Philip J, Gold M, Schwarz M, Komesaroff P

(2007), Intern Med J, 37(1), 49-55

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials

Keshaviah A, Dellapasqua S, Rotmensz N, Lindtner J, Crivellari D, Collins J, Colleoni M, Thürlimann B, Mendiola C, Aebi S, Price KN, Pagani O, Simoncini E, Castiglione Gertsch M, Gelber RD, Coates AS, Goldhirsch A

(2007), Ann Oncol, 18(4), 701-8

Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93

International Breast Cancer Study Group, Colleoni M, Gelber S, Simoncini E, Pagani O, Gelber RD, Price KN, Castiglione-Gertsch M, Coates AS, Goldhirsch A

(2007), Ann Oncol, 18(7), 1177-84

Experience with docetaxel in hormone-refractory prostate cancer (HRPC) at three Australian cancer centers: A retrospective study

Hovey E, Gabriel G, George M, Shapiro J, Chern B, Moylan E

(2007), Asia-Pacific J Clin Oncol, 3(3), 156-62

Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer

Goldstein D, Van Hazel G, Walpole E, Underhill C, Kotasek D, Michael M, Shapiro J, Davies T, Reece W, Harvey J, Spry N

(2007), Br J Cancer, 97(4), 464-71

Long-term survival and secondary acute leukemia after fotemustine therapy for metastatic melanoma

Gill S, Shapiro J, Westerman D, Prince HM

(2007), J Clin Oncol, 25(28), 4493-4

9 10 11 12